PPBT 株価推移チャート
PPBT 収入
Purple Biotech Ltd
$4.12
5.49%
$0.21
終値： May 08, 16:00:00 GMT-4
$3.95
-4.24%
$-0.17
アフターマーケット：May 08, 20:00:00 GMT-4
戻る
Purple Biotech Ltd (PPBT) 収入
主要データ
前終値
$3.91
始値
$4.08
当日レンジ
$3.95 - $4.19
52週レンジ
$3.6 - $29
取引高
3.3K
平均取引高
13.3K
配当利回り
--
1株当たり利益(TTM)
-54.00
時価総額
$3.6M
Purple Biotech Ltd.とは何ですか？
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
